Financial incentives created under the Affordable Care Act can help promote employer wellness programs and support preventive services utilization.
Postdischarge engagement of at-risk Medicaid beneficiaries in 6 health plans resulted in significant reductions in hospital readmissions at rates proportional to the frequency of engagement.
Rebecca W. Killon, MA, says addressing adherence of diabetes medication from the patient perspective can be very different from that of a physician.
Among outpatients who were screened for alcohol use, those with unhealthy alcohol use, women, and those who were older, white, and of lower socioeconomic status were more likely to use benzodiazepines.
The mean 24-week cost per participant was $5416 for extended-release injectable naltrexone (57% detoxification, 37% medication, 6% provider/patient) and $4148 for buprenorphine-naloxone (64% detoxification, 12% medication, 24% provider/patient).
A consumer survey on awareness, use, and trust of tiered provider networks indicated the need for increased consumer awareness of the networks.
Elderly patients prescribed drugs with a drug-laboratory black box warning (BBW) had lower rates of prescriber BBW compliance than patients prescribed drugs with a drug-disease warning.
Diagnosis-related group coding determines eligibility for many Medicare bundled payment initiatives. This approach excluded many patients with chronic obstructive pulmonary disease likely to benefit while including others without the disease.
This article provides an overview of the impact of specialty care and the opportunity for it to leapfrog primary care as a lead focus for accountable care.
Use of Toyota production system methods as part of a nosocomial MRSA prevention initiative on a surgical unit improved quality of care in other areas.
This study describes the patient characteristics and healthcare utilization of a chronic pain population within an integrated healthcare system in northern California.
Converting from analogue insulin to human insulin is associated with a clinical insignificant increase in glycated hemoglobin of 0.16% but with improved insulin adherence.